Bristol-Myers Squibb to buy Peninsula heart drug maker for $13.1 billion
October 05, 2020 at 11:10 AM EDT
The Stanford spinout launched in 2012 and went public in 2015 for $10 per share; now BMS will buy it for $225 per share.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|